Applying drug-eluting stents in clinical practice.
The use of percutaneous coronary interventions has resulted in significant improvement in patient care; however, the risk for restenosis remains a major limitation. Drug-eluting stents represent an impressive breakthrough in the evolution of interventional cardiology, but it is important to understand the limits to their added benefit. Safety of the procedure must continue to be the first consideration, and technique must not be compromised to accommodate new technology.
King
Spencer B
SB
Fuqua Heart Center at Piedmont Hospital, Atlanta, Georgia 30309, USA. spencer.king@piedmont.org
D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D003324:Coronary Artery Disease / Q000628:therapy*; D023903:Coronary Restenosis / Q000517:prevention & control*; D016503:Drug Delivery Systems; D004359:Drug Therapy, Combination; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D015607:Stents; D016896:Treatment Outcome; D050257:Tubulin Modulators / Q000008:administration & dosage
D010975:Platelet Aggregation Inhibitors; D050257:Tubulin Modulators